WASHINGTON—The World Bank on Monday pledged as much as $200 million in emergency funding to help three West African nations fight the deadly Ebola epidemic following requests from the World Health Organization and officials from the three countries.

The bank said the financing would help pay for medical supplies, salaries and other materials urgently needed to stabilize the health systems in Guinea, Liberia and Sierra Leone, where the death toll has reached nearly 900
I am very worried that many more lives are at risk unless we can stop this Ebola epidemic in its tracks," World Bank President Jim Yong Kim said in a statement.

"The international community needs to act fast to contain and stop this Ebola outbreak," said Dr. Kim, a global public-health expert.

WHO Director-General Margaret Chan said last week that the outbreak, the worst on record, was moving faster than efforts to control it. Authorities in Africa's most populous nation, Nigeria, have confirmed a second case and have quarantined eight individuals who helped treat a Liberian-American who died of the disease in July.
Dr. Chan said funding is vital to help authorities slow transmission and prevent spread of the disease to other areas.

"The demands created by this unprecedented outbreak outstrip the capacity of affected countries in West Africa to respond," she said.

WASHINGTON—The World Bank on Monday pledged as much as $200 million in emergency funding to help three West African nations fight the deadly Ebola epidemic following requests from the World Health Organization and officials from the three countries.

The bank said the financing would help pay for medical supplies, salaries and other materials urgently needed to stabilize the health systems in Guinea, Liberia and Sierra Leone, where the death toll has reached nearly 900
I am very worried that many more lives are at risk unless we can stop this Ebola epidemic in its tracks," World Bank President Jim Yong Kim said in a statement.

"The international community needs to act fast to contain and stop this Ebola outbreak," said Dr. Kim, a global public-health expert.

WHO Director-General Margaret Chan said last week that the outbreak, the worst on record, was moving faster than efforts to control it. Authorities in Africa's most populous nation, Nigeria, have confirmed a second case and have quarantined eight individuals who helped treat a Liberian-American who died of the disease in July.
Dr. Chan said funding is vital to help authorities slow transmission and prevent spread of the disease to other areas.

"The demands created by this unprecedented outbreak outstrip the capacity of affected countries in West Africa to respond," she said.

what the fxxxleh............in summary glove counter will benefit?????????

cvbgck..... where is your ball? supermax ceo equally bull as petronas' ceo. U better learn to make sure u know how to use your ball...i assume you r man enough

casperl... how did you derive the target:1.680....where there is no analyst covering this counter....sindiri hentam ah???? interesting number 168.....chinese like this number but need to justify yourselve

'Business costs rising, gov't must help'
The government should phase in subsidy cuts and be lenient in implementing goods and services tax (GST) as rising costs have already worsened Malaysia's business conditions, the Federation of Malaysian Manufacturers (FMM) said today.

'Business costs rising, gov't must help'
The government should phase in subsidy cuts and be lenient in implementing goods and services tax (GST) as rising costs have already worsened Malaysia's business conditions, the Federation of Malaysian Manufacturers (FMM) said today.

'Business costs rising, gov't must help'
The government should phase in subsidy cuts and be lenient in implementing goods and services tax (GST) as rising costs have already worsened Malaysia's business conditions, the Federation of Malaysian Manufacturers (FMM) said today.

MALAYSIA PRESS-Another electricity tariff hike in the offing in Malaysia-The Star

Wed Jun 25, 2014 12:30am GMT

MALAYSIA PRESS-Another electricity tariff hike in the offing in Malaysia-The Star

Wed Jun 25, 2014 12:30am GMT

MALAYSIA PRESS-Another electricity tariff hike in the offing in Malaysia-The Star

Wed Jun 25, 2014 12:30am GMT

GEORGE TOWN (June 23): Malaysia’s medical devices industry will face several major new developments over the next year that will unavoidably bring about tremendous impact on the sector and millions of consumers.

The first is the coming into force of the new Medical Device Regulations 2012.

In an unprecedented move, all companies that manufacture medical devices are required to apply for an “establishment licence” by the end of this month. They are also given one year to register their products, by July 1 next year.

The second is the imposition of the 6% Goods and Services Tax (GST) beginning April 1, 2015. There has been no mention from the government whether medical commodities will be exempted from the tax.

Both developments are expected to weigh in significantly on the industry - in terms of added procedures and commitments, as well as more costs.

For the Medical Device Regulations, a subsidiary legislation under the Medical Device Act 2012, is intended to enforce stringent high quality in products.

The list of items affected is vast and wide-ranging - from medical gloves to catheters, from syringes to needles and sutures, from medical and surgical X-ray apparatus to electro-medical equipment, dental instruments and medical furniture.

ben: Can post this question to the ceo at agm

GEORGE TOWN (June 23): Malaysia’s medical devices industry will face several major new developments over the next year that will unavoidably bring about tremendous impact on the sector and millions of consumers.

The first is the coming into force of the new Medical Device Regulations 2012.

In an unprecedented move, all companies that manufacture medical devices are required to apply for an “establishment licence” by the end of this month. They are also given one year to register their products, by July 1 next year.

The second is the imposition of the 6% Goods and Services Tax (GST) beginning April 1, 2015. There has been no mention from the government whether medical commodities will be exempted from the tax.

Both developments are expected to weigh in significantly on the industry - in terms of added procedures and commitments, as well as more costs.

For the Medical Device Regulations, a subsidiary legislation under the Medical Device Act 2012, is intended to enforce stringent high quality in products.

The list of items affected is vast and wide-ranging - from medical gloves to catheters, from syringes to needles and sutures, from medical and surgical X-ray apparatus to electro-medical equipment, dental instruments and medical furniture.


Read more: http://www.fz.com/content/new-developments-medical-devices-industry-next-year#ixzz35WcgpVN3

GEORGE TOWN (June 23): Malaysia’s medical devices industry will face several major new developments over the next year that will unavoidably bring about tremendous impact on the sector and millions of consumers.

The first is the coming into force of the new Medical Device Regulations 2012.

In an unprecedented move, all companies that manufacture medical devices are required to apply for an “establishment licence” by the end of this month. They are also given one year to register their products, by July 1 next year.

The second is the imposition of the 6% Goods and Services Tax (GST) beginning April 1, 2015. There has been no mention from the government whether medical commodities will be exempted from the tax.

Both developments are expected to weigh in significantly on the industry - in terms of added procedures and commitments, as well as more costs.

For the Medical Device Regulations, a subsidiary legislation under the Medical Device Act 2012, is intended to enforce stringent high quality in products.

The list of items affected is vast and wide-ranging - from medical gloves to catheters, from syringes to needles and sutures, from medical and surgical X-ray apparatus to electro-medical equipment, dental instruments and medical furniture.


Read more: http://www.fz.com/content/new-developments-medical-devices-industry-next-year#ixzz35WcgpVN3

The research house noted that alpha returns may be elusive in the sector, but Kossan Rubber Industries Bhd will outperform thanks to its breakthrough invention of the industry’s lightest (three gram) nitrile glove that complies with US FDA and EU requirement.

On the other players, AllianceDBS Research noted that Top Glove would need at least another year to improve its product mix and competitive advantage, Hartalega’s valuation is unattractive now, and Supermax’s expansion plan still lacks visibility.

jolie2 data give us idea of the industry. do homework as what you told. sharing as what we do

Lower glove exports to the US
By LIDIANA ROSLI - 10 June 2014 @ 11:55 PM

KUALA LUMPUR: Malaysia’s nitrile and natural rubber glove export market shares in the United States have fallen by four and five per cent, respectively, according to gloves manufacturer Supermax Corporation Bhd.

“According to a Malaysian Rubber Export Promotion Council report, Malaysia’s nitrile glove export market share fell by four per cent to 64 per cent in the first quarter,” said executive chairman cum managing director Datuk Seri Stanley Thai. “We also lost five per cent (to 58 per cent) for the export market share of natural rubber gloves,” he said on the sidelines of Invest Malaysia 2014.

He noted that while Malaysia’s export market share to the US fell, China’s gained four per cent for nitrile gloves and Thailand’s gained eight per cent for natural rubber gloves.

jolie2 you will make kossan ceo feel ashamed after you talk so highly on him and yet now, no such thing as "honest"..?

Disappointing results for glove sector players Glove makers delivered disappointing results for the first quarter financial year 2014 (1QFY14) due to weaker-than-expected sales volumes and margin compression.

AllianceDBS Research Sdn Bhd (AllianceDBS Research) in a sectoral outlook yesterday anticipate a mixed operating environment for glove makers with weak latex costs (positive), stable ringgit against dollar (neutral), and slowing glove consumption for the second half.

The research house noted that alpha returns may be elusive in the sector, but Kossan Rubber Industries Bhd will outperform thanks to its breakthrough invention of the industry’s lightest (three gram) nitrile glove that complies with US FDA and EU requirement.

On the other players, AllianceDBS Research noted that Top Glove would need at least another year to improve its product mix and competitive advantage, Hartalega’s valuation is unattractive now, and Supermax’s expansion plan still lacks visibility.

Read more: http://www.theborneopost.com/2014/06/14/disappointing-results-for-glove-sector-players/#ixzz352bV2Ve3

Disappointing results for glove sector players Glove makers delivered disappointing results for the first quarter financial year 2014 (1QFY14) due to weaker-than-expected sales volumes and margin compression.

AllianceDBS Research Sdn Bhd (AllianceDBS Research) in a sectoral outlook yesterday anticipate a mixed operating environment for glove makers with weak latex costs (positive), stable ringgit against dollar (neutral), and slowing glove consumption for the second half.

The research house noted that alpha returns may be elusive in the sector, but Kossan Rubber Industries Bhd will outperform thanks to its breakthrough invention of the industry’s lightest (three gram) nitrile glove that complies with US FDA and EU requirement.

On the other players, AllianceDBS Research noted that Top Glove would need at least another year to improve its product mix and competitive advantage, Hartalega’s valuation is unattractive now, and Supermax’s expansion plan still lacks visibility.

Read more: http://www.theborneopost.com/2014/06/14/disappointing-results-for-glove-sector-players/#ixzz352bV2Ve3

onederful to know this counter still many demand, wl drive up price. Need more buyers whenever epf sell

pressure sell down because EPF sells many lots from 1 week ago.

Disappointing results for glove sector players Glove makers delivered disappointing results for the first quarter financial year 2014 (1QFY14) due to weaker-than-expected sales volumes and margin compression.

AllianceDBS Research Sdn Bhd (AllianceDBS Research) in a sectoral outlook yesterday anticipate a mixed operating environment for glove makers with weak latex costs (positive), stable ringgit against dollar (neutral), and slowing glove consumption for the second half.

The research house noted that alpha returns may be elusive in the sector, but Kossan Rubber Industries Bhd will outperform thanks to its breakthrough invention of the industry’s lightest (three gram) nitrile glove that complies with US FDA and EU requirement.

On the other players, AllianceDBS Research noted that Top Glove would need at least another year to improve its product mix and competitive advantage, Hartalega’s valuation is unattractive now, and Supermax’s expansion plan still lacks visibility.

Read more: http://www.theborneopost.com/2014/06/14/disappointing-results-for-glove-sector-players/#ixzz352bV2Ve3

Since when talk fact is a sin and consider negative. We should encourage more courages msian talk fact....and not talk about tahi lembu. And Kossan CEO better set an example to the next generation. but why jolie2 you concerend since u know kossan ceo very well he is not the type that will push down the price.

Enter 2 months ago as what jolie2 been saying...until today jolie2 still sing the same song buy buy, bye2 or buy??


jolie2
After all the bad news, now come the "good" news (apply only to glove industry only)
The "Good" news is that msia will start to have the following health issue
a) middle east respiratory syndrome Coronal Virus, MERS-Cov
b) water borne disease outbreak -- cholera,thypoid .... many cases in klang area was reported due to water ration issue.
c) dengue cases is increasing

So to all cimb, amrearch, ta, kenanga , affin, rhb analyst .... pls write something to push up back the share price

NOW IS THE TIME TO BUYYYYYYYYYYYYYYYYYYYYYYYY after down for more than 1 week. Oversold position already. Time for rebound.

19/04/2014 19:57

EMPLOYEES PROVIDENT FUND BOARD
Disposed 12/06/2014 411,200
Changes in Substantial Shareholder's Interest Pursuant to Form 29B of the Companies Act. 1965

點看全文: http://biz.sinchew.com.my/node/96853?tid=23#ixzz34mPwrjSB

風險方面，安聯星展認為成本壓力和價格戰持續是領域的最大潛在挑戰，若手套業者礙於競爭壓力而難以將電費與天然氣售價調漲的額外成本壓力轉嫁給消費者，則可能對業績造成負面衝擊。

No wonder top glove up up up

KUALA LUMPUR (June 17): Top Glove Corporation Bhd said its net profit for third quarter to end-May 2014 rose 5.2% year- on-year to RM42.37 million, up from RM40.27 million in the similar quarter a year ago.

“This increase in profit was due to aggressive cost-discipline and cost-optimisation practices, via continuous automation,” said the world’s top glove maker in a press statement.



Read more: http://www.fz.com/content/top-glove-3q-profit-52-yoy-declares-7-sen-dividend#ixzz34x5wrvf0

Jolie2 where are you??????? how come Kossan is bleeding when the stupid supermax CEO simply open his mouth and talk nonsense during the invest msia forum..and yet supermax is doing fine.. where are you Jolie2

Jolie...only talk good about Kossan.... everything Kossan did is superb.....yehahhh gone with my fart....spot on!!!

Be Honest - should keep this in mind & should not jump conclusion TG is a bad counter, from the Chairman himself

TOP GLOVE, TOP QUALITY, TOP EFFICIENCY

GOOD HEALTH, SAFETY FIRST & BE HONEST



Tan Sri Lim Wee Chai

Glove firms to face margin squeeze

Author: value_investor | Publish date: Thu, 6 Mar 10:17 | >> Read article in Blog website


--------------------------------------------------------------------------------


Glovemakers have been enjoying relatively high profit margins, especially with nitrile gloves which command better margins than natural rubber gloves. But with a huge influx of nitrile glove capacity in the pipeline, couples with rising cost pressures, glovemakers are expected to face margin compression. "This year will be a challenging year in terms of managing costs pressures as well as selling prices pressures. We are enjoying margins of about 15%-16%, but with the incoming capacity and rising costs I expect to see margins coming down to about 9% to 11%," said Supermax Corp Bhd executive chairman and group managing director Datuk Seri Stanley Thai. (Financial Daily)




Source: CIMB Daybreak - 06 March 2014

well said....... yes, Kossan or Harta better investment

Des...never hope for anything xcept quick announce result....good stay, no good ...pack and bye....But now, dragging & dragging.....clearly, show you worse is coming

look at the bigger picture leh....tewnama

tewnama....depends on when you buy and when you sell loh.....really ah this tewnama

jackpot $$$$$$$$$$$

head on collision .....sorry, no airbag..........gone case.

see bursa guideline....must inform rsult no later 2 months from each closing qtr.....due already by this week ......surely this week

Karex rated 'add' by CIMB







0 0Google +0 00 comments



KUALA LUMPUR: CIMB Research rates Karex as 'add' with a target price of RM5.07 given that it had reported a strong 47 per cent increase in 1HFY14 net profit.

"This was in line with our expectation at 48 per cent of our FY14 forecast but above consensus at 55 per cent. The strong growth was driven by the increase in orders and greater economies of scale resulting from the higher condom capacity. Karex's utilisation rate remains at a high 81-82 per cent, indicating strong demand."

"CIMB maintains Karex's FY14-16 net profit forecasts but increase target price, now pegged to a higher 19 times CY15 price earnings ratio and at a 20 per cent premium over the rubber glove sector's average price earnings ratio.

"This is in line with the re-rating of the rubber glove sector's price earnings ratio. We maintain our Add rating on the stock, with the potential catalysts of strong results and higher liquidity from the bonus issue."

CIMB said it expects Karex to deliver strong results in 3QFY14.

"The full impact of the four new production lines has been reflected in the 2QFY14 results. However, the company has added another six production lines in the past few months.

"These lines have started operations and will make a partial quarter's contribution in 3QFY14. The lower latex price and stronger Malaysian ringgit/US dollar rate will boost Karex's earnings in 3QFY14."



Read more: Karex rated 'add' by CIMB - Latest - New Straits Times http://www.nst.com.my/business/latest/karex-rated-add-by-cimb-1.492024#ixzz2uEWITCl5

sure fly loh.....Kossan BOLEH

yeh...this week

also result no out, show you worse is coming, dare not to show, if good ah, already come out

don't hope more x for the worse trending downward